Notice Pursuant to the National Cooperative Research and Production Act of 1993-Biopharmaceutical Manufacturing Preparedness Consortium, 104212 [2024-30402]
Download as PDF
ddrumheller on DSK120RN23PROD with NOTICES1
104212
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
LLC, Reston, VA; Mindboard, Inc.,
Sterling, VA; Mosaic ATM, Inc.,
Leesburg, VA; N2L, Inc., New Market,
AL; National Instruments Corporation,
Austin, TX; North American Wave
Engine Corporation, Baltimore, MD;
Omnitek Partners, LLC, Ronkonkoma,
NY; Onyx Aerospace, Huntsville, AL;
Park-Tours, Inc., dba Left Coast
Engineering, Escondido, CA; Parry Labs,
LLC, Alexandria, VA; Phoenix Waste
Solutions, Inc., Chauvin, LA; Pliant
Energy Systems, Inc., Brooklyn, NY;
Polaris Sensor Technologies, Inc.,
Huntsville, AL; Precise Systems,
Lexington Park, MD; Qualcomm
Technologies, Inc., San Diego, CA; Raft,
LLC, Reston, VA; Rantec Power
Systems, Inc., Los Osos, CA;
RapidFlight Holdings, LLC, Manassas,
VA; Safire Technology Group, Inc.,
Mclean, VA; Skylark Labs, Inc., Dover,
DE; Strategic Technology Consulting,
LLC, Chantilly, VA; Strogen Strategic
Sustainability, LLC, Washington, DC;
Symbiosis.io, LLC, Smyrna, GA;
Tactical Electronics and Military
Supply, LLC, Broken Arrow, OK;
Tapestry Solutions, San Diego, CA; TDP,
Inc., Loveland, CO; The Dewey
Electronics Corporation, Oakland, NJ;
The Hard Yards, LLC, dba BlackSea
Technologies, Arlington, VA; The
Pennsylvania State University—Applied
Research Laboratory, State College, PA;
The Rector and Visitors of the
University of Virginia, Charlottesville,
VA; Tetramer Technologies, LLC,
Pendleton, SC; Tiami, LLC, Elk Grove,
CA; Tiger Team Engineering, LLC,
Sheridan, WY; Torch Technologies, Inc.,
Huntsville, AL; Trustees of Indiana
University, Bloomington, IN;
TurnAround Factor, Ashland, VA;
UberEther, Inc., Sterling, VA; Ultrasea,
Inc., East Kingston, NH; Universal
Solutions International, Inc., Newport
News, VA; Vega Technology Group,
LLC, North Canton, OH; Wright Electric,
Inc., Malta, NY; and WWM Solutions,
LLC, Washington, DC have been added
as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and EMC2 intends
to file additional written notifications
disclosing all changes in membership.
On January 11, 2024, EMC2 filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on March 13, 2024 (89 FR 18439).
The last notification was filed with
the Department on June 14, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
Act on September 12, 2024 (89 FR
74287).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–30416 Filed 12–19–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Biopharmaceutical
Manufacturing Preparedness
Consortium
Notice is hereby given that, on
October 3, 2024, pursuant to section 6(a)
of the National Cooperative Research
and Production Act of 1993, 15 U.S.C.
4301 et seq. (‘‘the Act’’),
Biopharmaceutical Manufacturing
Preparedness Consortium (‘‘BioMaPConsortium’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Asimov, Inc., Boston,
MA; Bayer Healthcare LLC, Whippany,
NJ; CHIMunomics, Ltd., Horsell,
UNITED KINGDOM; Carnegie Mellon
University, Pittsburgh, PA; Emergent
Product Development Gaithersburg,
Inc., Gaithersburg, MD; Enzene, Inc.,
Pennington, NJ; GE Medical Systems
Information Technologies, Inc. d.b.a. GE
HealthCare Technology & Innovation
Center, Niskayuna, NY; Just-Evotec
Biologics, Seattle, WA; Medbio LLC,
Grand Rapids, MI; Molding Services of
Illinois, Inc., Olney, IL; Novas Bio, Inc.,
Union City, CA; Qoolabs, Inc., Carlsbad,
CA; SPOC Proteomics, Inc., Scottsdale,
AZ; SaniSure, Inc., Camarillo, CA;
AlphaGem Bio, Inc., Fremont, CA;
Azure Medical, Inc., La Verne, CA;
BioFactura, Inc., Frederick, MD;
Brightstar Innovations Group LLC,
Arlington, VA; Croda, Inc., Mill Hall,
PA; Hamilton Company, Reno, NV;
Komo Biosciences, Inc., Cambridge,
MA; Mustard Seed PMO LLC, West
Chester, PA; Nephron Nitrile LLC, West
Columbia, SC; Rutgers University,
Piscataway, NJ; The Tiny Cargo
Company, Roanoke, VA; VGXI, Inc.,
Conroe, TX; Wild Microbes Company,
Cambridge, MA; Arcology, Inc., Culver
City, CA; Avery Digital Data, Inc., La
Jolla, CA; Louis M Gerson Co, Inc.,
Middleboro, MA; Mark Cuban Cost Plus
PO 00000
Frm 00141
Fmt 4703
Sfmt 9990
Drug Company, PBC, Dallas, TX; Vulcan
Bioworks LLC, Dover, DE; Arcturus
Therapeutics Holdings, Inc., San Diego,
CA; Dentec Safety Specialists Corp.,
Lenexa, KS; Guide Biomedical Solutions
LLC, Media, PA; Integral Molecular,
Philadelphia, PA; Shreenika Pioneering,
San Diego, CA; Applied Research
Associates, Albuquerque, NM;
DemeTech Corp., Miami, FL; Quantoom
Biosciences SA, Nivelles, BELGIUM;
Reusable Respirators LLC, Panama City,
FL; SafeSource Direct, LLC, Broussard,
LA; Vaxine Pty Ltd., Warradale,
AUSTRALIA; 3M Company, St. Paul,
MN; Amneal Pharmaceuticals of New
York, LLC, Brookhaven, NY; CMMCM
LLC, Las Vegas, NV; Foothill Scientific
Associates, Lake Forest, CA; Innerspace
GmbH, Insnbruck, AUSTRIA; Jurata
Thin Film, Inc., Chapel Hill, NC; LTS
Lohmann Therapie-Systeme AG,
Andernach, GERMANY; O&M Halyard,
Inc., Alpharetta, GA; PNUVAX, Inc.,
Wilmington, DE; Pacto Medical, Inc.,
Newark, DE; Shawmut LLC, West
Bridgewater, MA; US Medical Glove,
Harvard, IL; Univercells S.A., Charleroi,
BELGIUM; and Vivaldi Biosciences Inc.,
Fort Collins, CO, have been added as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and the BioMaPConsortium intends to file additional
written notifications disclosing all
changes in membership.
On January 5, 2024, the BioMaPConsortium filed its original notification
pursuant to section 6(a) of the Act. The
Department of Justice published a notice
in the Federal Register pursuant to
section 6(b) of the Act on April 16, 2024
(89 FR 26923).
The last notification was filed with
the Department on July 11, 2024. The
Department of Justice published a notice
in the Federal Register pursuant to
section 6(b) of the Act on October 11,
2024 (89 FR 82628).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–30402 Filed 12–19–24; 8:45 am]
BILLING CODE P
E:\FR\FM\20DEN1.SGM
20DEN1
Agencies
[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Page 104212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30402]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Biopharmaceutical Manufacturing Preparedness
Consortium
Notice is hereby given that, on October 3, 2024, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Biopharmaceutical
Manufacturing Preparedness Consortium (``BioMaP-Consortium'') has filed
written notifications simultaneously with the Attorney General and the
Federal Trade Commission disclosing changes in its membership. The
notifications were filed for the purpose of extending the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances.
Specifically, Asimov, Inc., Boston, MA; Bayer Healthcare LLC,
Whippany, NJ; CHIMunomics, Ltd., Horsell, UNITED KINGDOM; Carnegie
Mellon University, Pittsburgh, PA; Emergent Product Development
Gaithersburg, Inc., Gaithersburg, MD; Enzene, Inc., Pennington, NJ; GE
Medical Systems Information Technologies, Inc. d.b.a. GE HealthCare
Technology & Innovation Center, Niskayuna, NY; Just-Evotec Biologics,
Seattle, WA; Medbio LLC, Grand Rapids, MI; Molding Services of
Illinois, Inc., Olney, IL; Novas Bio, Inc., Union City, CA; Qoolabs,
Inc., Carlsbad, CA; SPOC Proteomics, Inc., Scottsdale, AZ; SaniSure,
Inc., Camarillo, CA; AlphaGem Bio, Inc., Fremont, CA; Azure Medical,
Inc., La Verne, CA; BioFactura, Inc., Frederick, MD; Brightstar
Innovations Group LLC, Arlington, VA; Croda, Inc., Mill Hall, PA;
Hamilton Company, Reno, NV; Komo Biosciences, Inc., Cambridge, MA;
Mustard Seed PMO LLC, West Chester, PA; Nephron Nitrile LLC, West
Columbia, SC; Rutgers University, Piscataway, NJ; The Tiny Cargo
Company, Roanoke, VA; VGXI, Inc., Conroe, TX; Wild Microbes Company,
Cambridge, MA; Arcology, Inc., Culver City, CA; Avery Digital Data,
Inc., La Jolla, CA; Louis M Gerson Co, Inc., Middleboro, MA; Mark Cuban
Cost Plus Drug Company, PBC, Dallas, TX; Vulcan Bioworks LLC, Dover,
DE; Arcturus Therapeutics Holdings, Inc., San Diego, CA; Dentec Safety
Specialists Corp., Lenexa, KS; Guide Biomedical Solutions LLC, Media,
PA; Integral Molecular, Philadelphia, PA; Shreenika Pioneering, San
Diego, CA; Applied Research Associates, Albuquerque, NM; DemeTech
Corp., Miami, FL; Quantoom Biosciences SA, Nivelles, BELGIUM; Reusable
Respirators LLC, Panama City, FL; SafeSource Direct, LLC, Broussard,
LA; Vaxine Pty Ltd., Warradale, AUSTRALIA; 3M Company, St. Paul, MN;
Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY; CMMCM LLC, Las
Vegas, NV; Foothill Scientific Associates, Lake Forest, CA; Innerspace
GmbH, Insnbruck, AUSTRIA; Jurata Thin Film, Inc., Chapel Hill, NC; LTS
Lohmann Therapie-Systeme AG, Andernach, GERMANY; O&M Halyard, Inc.,
Alpharetta, GA; PNUVAX, Inc., Wilmington, DE; Pacto Medical, Inc.,
Newark, DE; Shawmut LLC, West Bridgewater, MA; US Medical Glove,
Harvard, IL; Univercells S.A., Charleroi, BELGIUM; and Vivaldi
Biosciences Inc., Fort Collins, CO, have been added as parties to this
venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and the BioMaP-Consortium intends to
file additional written notifications disclosing all changes in
membership.
On January 5, 2024, the BioMaP- Consortium filed its original
notification pursuant to section 6(a) of the Act. The Department of
Justice published a notice in the Federal Register pursuant to section
6(b) of the Act on April 16, 2024 (89 FR 26923).
The last notification was filed with the Department on July 11,
2024. The Department of Justice published a notice in the Federal
Register pursuant to section 6(b) of the Act on October 11, 2024 (89 FR
82628).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-30402 Filed 12-19-24; 8:45 am]
BILLING CODE P